These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11295430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
    Paeng JC, Jeong JM, Yoon CJ, Lee YS, Suh YG, Chung JW, Park JH, Chung JK, Son M, Lee MC.
    J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
    [Abstract] [Full Text] [Related]

  • 3. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
    Luo TY, Hsieh BT, Wang SJ, Lin WY, Lee TW, Shen LH, Su MJ.
    Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of 188 Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer.
    Lee YS, Jeong JM, Kim YJ, Chung JW, Park JH, Suh YG, Lee DS, Chung JK, Lee MC.
    Nucl Med Commun; 2002 Mar; 23(3):237-42. PubMed ID: 11891481
    [Abstract] [Full Text] [Related]

  • 5. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
    Lee YS, Jeong JM, Kim YJ, Chang YS, Lee HJ, Son M, Lee JW, Yoon HS, Kang WJ, Lee DS, Chung JK, Lee MC, Suh YG.
    Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol.
    Banka VK, Moon SH, Jeong JM, Seelam SR, Lee YS, Kim YJ, Lee DS, Chung JK.
    Nucl Med Biol; 2015 Mar; 42(3):317-22. PubMed ID: 25537725
    [Abstract] [Full Text] [Related]

  • 14. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
    Lambert B, Bacher K, Defreyne L, Van Vlierberghe H, Jeong JM, Wang RF, van Meerbeeck J, Smeets P, Troisi R, Thierens H, De Vos F, Van de Wiele C.
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma.
    Uccelli L, Pasquali M, Boschi A, Giganti M, Duatti A.
    Nucl Med Biol; 2011 Feb; 38(2):207-13. PubMed ID: 21315276
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.